Imidazenil: Potent Non-Sedating Anticonvulsant and Anxiolytic for Pharmaceutical Research

Explore the advanced properties of Imidazenil, a leading pharmaceutical intermediate for developing novel treatments for anxiety and epilepsy. Discover its unique benefits as a selective GABA A receptor modulator.

Get a Quote & Sample

Key Advantages of Using Imidazenil

Selective GABA A Receptor Modulation

Imidazenil acts as a potent partial agonist at GABA A receptors, influencing specific subtypes to achieve therapeutic effects without common benzodiazepine drawbacks.

Non-Sedating Anxiolytic and Anticonvulsant Properties

Unlike traditional benzodiazepines, Imidazenil offers significant anxiolytic and anticonvulsant benefits without inducing sedation or amnesia, making it ideal for complex therapeutic applications.

Potential in Complex Neurological Conditions

Studies suggest Imidazenil's utility in treating conditions like anxiety disorders, epilepsy, and even as a protective agent against organophosphate nerve agent toxicity, offering a flexible antidote option.

Applications of Imidazenil in Pharmaceutical R&D

Neuroscience Research

Utilize Imidazenil CAS 151271-08-8 as a research chemical to explore GABAergic system mechanisms and develop novel neurological therapies.

Pharmaceutical Synthesis

Source Imidazenil as a high-purity intermediate from our facility in China for complex pharmaceutical synthesis pathways.

Drug Discovery Programs

Investigate Imidazenil for its anxiolytic and anticonvulsant potential in drug discovery programs targeting CNS disorders.

Chemical Supply Chain

Partner with NINGBO INNO PHARMCHEM CO.,LTD. for a stable supply of Imidazenil, ensuring your R&D pipeline remains uninterrupted.